We are tempted to speculate that changes in CSF Gpc2 levels may be observed in depression and Alzheimer’s disease, human diseases in which a reduction in adult neurogenesis has been described69, 70. Here, GPC2 is linked to early-onset autosomal dominant Alzheimer disease.